Pancreatic Carcinoma — Trials

Pancreatic Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

1,381 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 488
Recruiting: 282
Ph III recruiting: 29
Growth YoY: +31.5%
Industry share: 36%
Top sponsor: National Cancer Institute (NCI)
Termination share: 37.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (201)

clinicaltrialsPublishedShowing 51–100 of 134 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07199764	Maintenance Combinatorial Myeloid Immunotherapy for Unresectable Pancreatic Cancer(IGNITE)	recruiting	Phase 2	100	University of PennsylvaniaOTHER	1	Jun 10, 2026	clinicaltrials
NCT07226856	BMS-986340 in Combination With Nivolumab, Gemcitabine and Nab-paclitaxel for the Treatment of Metastatic and Recurrent Pancreatic Adenocarcinoma	recruiting	Phase 2	43	Mayo ClinicOTHER	1	Jun 9, 2026	clinicaltrials